2012 / Editorial / commentary on a randomized phase II trial
A commentary reports that 60 g/day of strawberry powder reduced the histologic grade of dysplastic lesions in an esophageal cancer prevention trial.
This commentary discusses a randomized noncomparative phase II trial in China testing two doses of strawberry powder (60 g/d or 30 g/d for six months) to prevent esophageal cancer. The 60 g/d dose reduced the histologic grade of dysplastic lesions and reduced localized biomarkers, whereas the 30 g/d dose was not effective. The author notes that fundamental questions remain regarding formulation, active components, and mechanisms of action.
Suh N, Pezzuto JM Cancer Prev Res (Phila), 2012. PMID 22219164